INTRODUCTION: The efficacy of hydroxocobalamin for acute cyanide poisoning was compared with that of saline vehicle in dogs. METHODS: Anesthetized adult beagle dogs were administered potassium cyanide (0.4 mg/kg/min, IV) until 3 min after the onset of apnea. Hydroxocobalamin (75 mg/kg [n = 19] or 150 mg/kg [n = 18], IV) or saline vehicle [n = 17] was then infused over 7.5 min while animals were ventilated with 100% oxygen, which was stopped after 15 min. RESULTS: In vehicle-treated animals cyanide produced deterioration that culminated in a moribund state requiring euthanasia within 4 h in 10 of 17 animals and in neurological deficits necessitating euthanasia within 2-4 d in an additional 4 animals (mortality rate 82%). Survival through 14 d was observed in 15 of 19 animals administered hydroxocobalamin 75 mg/kg (mortality rate 21%), and 18 of 18 administered hydroxocobalamin 150 mg/kg (mortality rate 0%). CONCLUSION: Hydroxocobalamin reversed cyanide toxicity and reduced mortality in a canine model.
INTRODUCTION: The efficacy of hydroxocobalamin for acute cyanidepoisoning was compared with that of saline vehicle in dogs. METHODS: Anesthetized adult beagle dogs were administered potassium cyanide (0.4 mg/kg/min, IV) until 3 min after the onset of apnea. Hydroxocobalamin (75 mg/kg [n = 19] or 150 mg/kg [n = 18], IV) or saline vehicle [n = 17] was then infused over 7.5 min while animals were ventilated with 100% oxygen, which was stopped after 15 min. RESULTS: In vehicle-treated animals cyanide produced deterioration that culminated in a moribund state requiring euthanasia within 4 h in 10 of 17 animals and in neurological deficits necessitating euthanasia within 2-4 d in an additional 4 animals (mortality rate 82%). Survival through 14 d was observed in 15 of 19 animals administered hydroxocobalamin 75 mg/kg (mortality rate 21%), and 18 of 18 administered hydroxocobalamin 150 mg/kg (mortality rate 0%). CONCLUSION:Hydroxocobalamin reversed cyanidetoxicity and reduced mortality in a canine model.
Authors: Vikhyat S Bebarta; Matthew Brittain; Adriano Chan; Norma Garrett; David Yoon; Tanya Burney; David Mukai; Michael Babin; Renate B Pilz; Sari B Mahon; Matthew Brenner; Gerry R Boss Journal: Ann Emerg Med Date: 2016-12-29 Impact factor: 5.721
Authors: Adriano Chan; Daune L Crankshaw; Alexandre Monteil; Steven E Patterson; Herbert T Nagasawa; Jackie E Briggs; Joseph A Kozocas; Sari B Mahon; Matthew Brenner; Renate B Pilz; Timothy D Bigby; Gerry R Boss Journal: Clin Toxicol (Phila) Date: 2011-06 Impact factor: 4.467
Authors: Matthew Brenner; Sari B Mahon; Jangwoen Lee; Jae Kim; David Mukai; Seth Goodman; Kelly A Kreuter; Rebecca Ahdout; Othman Mohammad; Vijay S Sharma; William Blackledge; Gerry R Boss Journal: J Biomed Opt Date: 2010 Jan-Feb Impact factor: 3.170
Authors: Steven E Patterson; Bryant Moeller; Herbert T Nagasawa; Robert Vince; Daune L Crankshaw; Jacquie Briggs; Michael W Stutelberg; Chakravarthy V Vinnakota; Brian A Logue Journal: Ann N Y Acad Sci Date: 2016-06-16 Impact factor: 5.691
Authors: Bryant M Moeller; Daune L Crankshaw; Jacquie Briggs; Herbert T Nagasawa; Steven E Patterson Journal: Toxicol Lett Date: 2017-04-12 Impact factor: 4.372
Authors: Vikhyat S Bebarta; David A Tanen; Susan Boudreau; Maria Castaneda; Lee A Zarzabal; Toni Vargas; Gerry R Boss Journal: Ann Emerg Med Date: 2014-04-18 Impact factor: 5.721